ZOM - Zomedica GAAP EPS of -$0.05 misses by $0.04 revenue of $4.1M misses by $0.3M
Zomedica press release (NYSE:ZOM): FY GAAP EPS of -$0.05 misses by $0.04. Revenue of $4.1M misses by $0.3M. Shares +16.7%. As of December 31, 2020, we had an accumulated deficit of approximately $69.0 million and cash and cash equivalents of approximately $62.0 million. 10K
For further details see:
Zomedica GAAP EPS of -$0.05 misses by $0.04, revenue of $4.1M misses by $0.3M